Healthcare (Basel). 2026 Mar 27;14(7):860. doi: 10.3390/healthcare14070860.

ABSTRACT

Background and Objectives: This study aimed to evaluate the effectiveness of Transfer of Energy Capacitive and Resistive (TECAR) therapy in treating active myofascial trigger points (MTrPs) in the upper trapezius muscle (UT) and to compare it with the effects of dry needling (DN). Materials and Methods: We recruited 29 men (mean age: 35.52 ± 5.73 years) with active MTrPs in the UT. Participants were randomly assigned to two groups: TECAR (n = 17) and DN (n = 12). Treatment was administered twice, with a 7-day interval between sessions. PPT, pain intensity (NRS), UT muscle strength (dynamometer), and cervical spine range of motion (ROM) were measured before treatment, immediately after each therapy session, and at a 30-day follow-up. Data were analyzed using parametric or non-parametric tests depending on data distribution (p < 0.05). Results: Both groups showed significant increases in PPT, but TECAR reduced NRS significantly more than DN (p < 0.001), demonstrating superior immediate analgesia. While TECAR temporarily decreased unaffected UT strength, it provided broader improvements in cervical mobility (flexion: 19.5%, contralateral rotation: 13.1%). Over 30 days, both groups improved PPT (TECAR: ~110%; DN: ~63%) and NRS (TECAR: ~97.1%; DN: ~84.5%). The TECAR group consistently outperformed DN in long-term pain reduction and achieved more substantial improvements in ROM. Conclusions: TECAR therapy appears to provide immediate and longer-term analgesic effects in the treatment of active MTrPs in the UT, although its impact on cervical ROM seems relatively limited compared with DN. It may therefore represent a useful, though less commonly applied, option for MTrPs management.

PMID:41975862 | DOI:10.3390/healthcare14070860